About 84 employees are affected, about 45% of its workforce, according to Bionano Genomics, Inc.'s latest layoff filing, on September 9, 2024. As of November 14, 2026, Bionano Genomics, Inc. has reported 3 exit or restructuring plans to the SEC on Form 8-K under Item 2.05. No WARN notice under its name is on file in the states covered here (Form 8-K, September 9, 2024).
10 companies announced layoffs this week, 1 had other signals.
Companies cutting jobs this week. Before you unlock: the company, the number of employees and what is inside. After: every way we found to reach the company. No individual is named in a layoff.
| UPWORK, INC | announced layoffs | |
| PVH CORP. /DE/ | announced layoffs | |
| Battelle | filed a layoff notice for 15 employees | |
| TidalHealth Primary Care | filed a layoff notice for 5 employees | |
| Phunware, Inc. | announced layoffs |
Is this your company?
Owed money by them or selling to them? See the free Snapshot of Bionano Genomics, Inc.
Free to see. No signup.
People from Bionano Genomics, Inc. who say they are open to work
Only people who added themselves are listed here. Nobody is named because of a company announcement or a news story, and we have not checked what anyone says about themselves.
Loading the list…
Affected by the Bionano Genomics, Inc. layoff? Add yourself to the open-to-work list, free
Your entry
Bionano Genomics, Inc. reported 3 exit or restructuring plans on Form 8-K under Item 2.05, 2 of 3 stating how many employees or positions are affected. Each fact below is the filing's own sentence, quoted and linked. No WARN notice under this company's name is on file in the states covered here.
Did Bionano Genomics have layoffs in 2024? What its filings say
Bionano Genomics, Inc. (CIK 1411690) reported 3 exit or restructuring plans to the SEC on Form 8-K under Item 2.05. The sentences below are quoted from the filings as written.
Form 8-K filed 2024-09-09
Employees affected
As part of the Reduction, the Company expects to reduce its overall headcount by approximately 84 employees, which represents approximately 45% of its full-time employees as of September 3, 2024.
Expected charges
The Company estimates that it will incur total restructuring charges of approximately $0.5 million to $1.0 million, including severance payments in connection with the Plan.
Timing
The Company expects the Reduction will be substantially completed by October 1, 2024.
Form 8-K filed 2024-05-08
Expected charges
The Company has now determined that the Reduction is expected to result in total restructuring charges of approximately $4.6 million, including $3.9 million, comprised primarily of severance payments and wages for the 60-day notice period in accordance with the California Worker Adjustment and Retraining Notification (WARN) Act and $0.2 million in connection with lease terminations.
Timing
The Company expects the Reduction will be substantially completed by June 30, 2024.
Form 8-K filed 2024-03-05
Employees affected
As part of the Reduction, the Company expects to reduce its overall headcount by approximately 110 to 125 employees, which represents approximately 34% to 39% of its full-time employees as of the date of this Current Report on Form 8-K. In addition to the Reduction, Bionano Laboratories intends to phase out the offering of certain testing services related to neurodevelopmental disorders, including autism spectrum disorders and other disorders of childhood development (the "Products").
Expected charges
These cost-saving measures from the Plan are incremental to the cost saving initiatives previously announced in May 2023 and October 2023 and are expected to provide additional annual savings of operating expenses, of approximately $35.0 to $40.0 million starting in the second half of 2024.
Also on the record for Bionano Genomics, Inc.
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| October 19, 2026 | Stake report, Schedule 13G, by Orin Hirschman | 9.9% of the class | 5%+ stakes | Source |
| August 14, 2026 | Stake report, Schedule 13G/A, by CVI Investments, Inc. | 9.9% of the class | 5%+ stakes | Source |
| June 5, 2026 | Leadership change filing (Form 8-K, Item 5.02) | — | Leadership changes | Source |
| May 6, 2026 | Leadership change: R. Erik Holmlin departs, and 1 more | — | Leadership changes | Source |
| February 17, 2026 | Stake report, Schedule 13G/A, by CVI Investments, Inc. | 9.9% of the class | 5%+ stakes | Source |
| February 17, 2026 | Stake report, Schedule 13G/A, by Lind Global Fund III LP | 9.35% of the class | 5%+ stakes | Source |
| November 14, 2025 | Stake report, Schedule 13G/A, by Iroquois Capital Management, LLC | 4.99% of the class | 5%+ stakes | Source |
| November 14, 2025 | Stake report, Schedule 13G/A, by Lind Global Fund III LP | 9.9% of the class | 5%+ stakes | Source |
| November 14, 2025 | Stake report, Schedule 13G/A, by Richard Abbe | 4.99% of the class | 5%+ stakes | Source |
| November 13, 2025 | Stake report, Schedule 13G, by Ayrton Capital LLC | 9.99% of the class | 5%+ stakes | Source |
| September 24, 2025 | Stake report, Schedule 13G, by Lind Global Fund III LP | 9.9% of the class | 5%+ stakes | Source |
| September 22, 2025 | Stake report, Schedule 13G, by CVI Investments, Inc. | 9.9% of the class | 5%+ stakes | Source |
Keep reading
More on Bionano Genomics, Inc. and the records around it.
Bionano Genomics, Inc. elsewhere on the record
- 5%+ stake filings Oct 2026
- Leadership changes Jun 2026
- Who owns it
Companies that share a holder
- Lind Global Fund III LP also filed stake reports on 11 other companies: Dare Bioscience, Inc. (Aug 2026), DEFSEC Technologies Inc. (Aug 2026), Enveric Biosciences, Inc. (Aug 2026)
- Iroquois Capital Management, LLC also filed stake reports on 13 other companies: 22nd Century Group (Aug 2026), XWELL, Inc. (Aug 2026), Clearmind Medicine Inc. (Aug 2026)
- Lincoln Alternative Strategies LLC also filed stake reports on 13 other companies: Celularity Inc (Feb 2026), GRI Bio, Inc. (Feb 2026), Jaguar Health, Inc. (Feb 2026)
Watch Bionano Genomics, Inc.
Get an email when Bionano Genomics, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
What do you want to do with Bionano Genomics, Inc.?
Want the whole picture on Bionano Genomics, Inc.?
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Bionano Genomics, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Bionano Genomics, Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
15 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
The newest 12 of 15 records.
Tools for this story
Each opens in a new tab, filled in for Bionano Genomics, Inc.. With no account yet, you sign up free and land on the result.
Public companies must also report to the SEC, on Form 8-K under Item 2.05, when they commit to an exit or restructuring plan that will cost them material charges, which is how most large layoffs and closures by listed companies are disclosed. Those filings are national, so they cover companies in every state. Each sentence shown from one is quoted exactly and linked to the filing; where a filing does not state a figure, none is shown.
Where this comes from
Employers covered by the federal WARN Act, and by the stricter laws some states add, must give written notice before a mass layoff or a site closure. The state labor department publishes those notices. Every row here is one of them, taken from that state's own published file and linked to it, so each figure can be checked at the source.
A notice states the employer, the location, the number of employees affected, and when the layoff or closure takes effect. It does not state a reason, and neither does this page. Where a company also appears in SEC filings under the same name and in the same state, its recorded fundraising is shown alongside, as a matter of record rather than as an explanation. New Jersey and Pennsylvania list a notice under the month it was posted or received, not the day, so their notices show a month. Tennessee gives the county rather than the city.
Who owns Bionano Genomics, Inc.? Owners, funding and legal record
Cite this page
https://mentionfox.com/layoffs/bionano-genomics